• Ambler, J. & Wallis, R.B. (1983). A comparison between platelet aggregation and ATP secretion induced by collagen and by PAF acether and their inhibition by phenylbutazone, sulphinpyrazone and its metabolites. Thrombos. Res., 31, 577589.
  • Aster, R.H. & Jandl, J.H. (1964). Platelet sequestration in man. 1. Methods. J. clin. Invest., 43, 843855.
  • Butler, K.D., Maguire, E.D., Smith, J.R., Turnbull, A.A., Wallis, R.B. & White, A.M. (1982). Prolongation of rat tail bleeding time caused by oral doses of a thromboxane synthetase inhibitor which have little effect on platelet aggregation. Thrombos. Haemostas., 47, 4649.
  • Butler, K.D., Pay, G.F., Roberts, J.M. & White, A.M. (1979b). The effect of sulphinpyrazone and other drugs on the platelet response during the acute phase of the active Arthus reaction in guinea pigs. Thrombos. Res., 15, 319340.
  • Butler, K.D., Wallis, R.B. & White, A.M. (1979a). A study of the relationship between ex vivo and in vivo effects of sulphinpyrazone in the guinea pig. Haemostasis, 8, 353360.
  • Butler, K.D. & White, A.M. (1980a). Inhibition of platelet involvement in the sub-lethal Forssman reaction by sulphinpyrazone. In Cardiovascular Actions of Sulphinpyrazone - Basic and Clinical Research. ed. McGregor, M., Mustard, J.F., Oliver, M. & Sherry, S. pp. 115. Symposium Specialists Inc., U.S.A.
  • Butler, K.D. & White, A.M. (1980b). Inhibition of thrombocytopenia episodes caused by the Arthus reaction, the sub-lethal Forssman reaction and ADP. Artery, 8, 457469.
  • Dejana, E., Callioni, A., Quintana, A. & De Gaetano, G. (1979). Bleeding time in laboratory animals. II. A comparison of different assay conditions in rats. Thrombos. Res., 15, 191197.
  • Dodd, N.J., Gordge, M.P. & Weston, M.J. (1983). Use of a thromboxane synthetase inhibitor dazoxiben during haemodialysis. Br. J. clin. Pharmac., 15, 67s70s.
  • Gryglewski, R.J., Bunting, S., Moncada, S., Flower, R.J. & Vane, J.R. (1976). Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins, 12, 685713.
  • Hulliger, L. & Blazkovec, A.A. (1967). A simple and efficient method of separating peripheral blood leucocytes for in vitro studies. Lancet, 1, 13041305.
  • Ku, E.C., McPherson, S.E., Signor, C., Chertock, H. & Cash, W.D. (1983). Characterisation of imidazo 1,5a pyridine-5-hexanoic acid (CGS 13080) as a selective thromboxane synthetase inhibitor using in vitro and in vivo biochemical models. Biochem. biophys. Res. Commun., 112, 899906.
  • Macnab, M.W., Foltz, E.L., Graves, B.S., Rinehart, R.K., Tripp, S.L., Feliciano, N.R. & Sen, S. (1984). The effects of a new thromboxane synthetase inhibitor, CGS 13080 in man. J. clin. Pharmac., 24, 7683.
  • Maguire, E.D. & Wallis, R.B. (1983). In vivo redirection of prostaglandin endoperoxides into 6 keto PGF1α formation by thromboxane synthetase inhibitors in the rat. Thrombos. Res., 32, 1527.
  • Moncada, S., Bunting, S., Mullane, K., Thorogood, P., Vane, J.R., Raz, A. & Needleman, P. (1977). Imidazole: A selective inhibitor of thromboxane synthetase. Prostaglandins, 13, 611618.
  • Needleman, P., Minkes, M. & Raz, M. (1976a). Thromboxanes: Selective biosynthesis and distinct biological properties. Science, 193, 163165.
  • Needleman, P., Moncada, S., Bunting, S., Vane, J.R., Hamberg, M. & Samuelsson, B. (1976b). Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides. Nature, 261, 558560.
  • Parry, M.J. (1983). Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour. Br. J. clin. Pharmac., 15 (Suppl. 1), 233.
  • Smith, J.R. & White, A.M. (1982). Fibrin, red cell and platelet interactions in an experimental model of thrombosis. Br. J. Pharmac., 77, 2338.
  • Takaguchi, C., Kohno, E. & Sih, C.J. (1971). Mechanism of prostaglandin biosynthesis. 1. Characterisation and assay of bovine prostaglandin synthetase. Biochemistry, 10, 23722376.
  • Tyler, H.M., Saxton, C.A.P.D. & Parry, M.J. (1981). Administration to man of UK 37,248-01, a selective inhibitor of thromboxane synthetase. Lancet, 1, 629632.